Table of contents
Volume 92, Issue 1
Published online 14 January 2005 (1-208)
Minireview |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor
Editorials
Editorial FREE
A L Harris Editor-in-Chief
Br J Cancer 92: 1-2; doi:10.1038/sj.bjc.6602356
Lymph node status in screen-detected cancers FREE
S W Duffy
Br J Cancer 92: 3-4; doi:10.1038/sj.bjc.6602290
Endostatin in the pancreas FREE
S J Wigmore
Br J Cancer 92: 5-6; doi:10.1038/sj.bjc.6602180
Minireview
Clinical anticancer drug development: targeting the cyclin-dependent kinases FREE
C Benson, S Kaye, P Workman, M Garrett, M Walton and J de Bono
Br J Cancer 92: 7-12; advance online publication, November 23, 2004; doi:10.1038/sj.bjc.6602229
Clinical Studies
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy FREE
F Barlési, C Tchouhadjian, C Doddoli, J-P Torre, P Astoul and J-P Kleisbauer
Br J Cancer 92: 13-14; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602296
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment FREE
F M Wachters, H J M Groen, B Biesma, F M N H Schramel, P E Postmus, J A Stigt and E F Smit
Br J Cancer 92: 15-20; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602268
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas FREE
N B Jamieson, P Glen, D C McMillan, C J McKay, A K Foulis, R Carter and C W Imrie
Br J Cancer 92: 21-23; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602305
Adjuvant sequential methotrexate 
5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer FREE
A Sobrero, G Frassineti, A Falcone, L Dogliotti, R Rosso, F D Costanzo and P Bruzzi on behalf of the INTACC
Br J Cancer 92: 24-29; advance online publication, December 21, 2004; doi:10.1038/sj.bjc.6602276
p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan FREE
L-L Hsieh, T-H Huang, I-H Chen, C-T Liao, H-M Wang, C-H Lai, S-H Liou, J T-C Chang and A-J Cheng
Br J Cancer 92: 30-35; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602271
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding FREE
J Shamash, G Dancey, C Barlow, P Wilson, W Ansell and R T D Oliver
Br J Cancer 92: 36-40; advance online publication, November 30, 2004; doi:10.1038/sj.bjc.6602263
Correlation between the tumoral expression of 
3-integrin and outcome in cervical cancer patients who had undergone radiotherapy FREE
G Gruber, J Hess, C Stiefel, D M Aebersold, Y Zimmer, R H Greiner, U Studer, H J Altermatt, R Hlushchuk and V Djonov
Br J Cancer 92: 41-46; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602278
The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer FREE
R S Day, S E Shackney and W P Peters
Br J Cancer 92: 47-54; doi:10.1038/sj.bjc.6602267
Case-mix fails to explain variation in mastectomy rates: management of screen-detected breast cancer in a UK region 1997–2003 FREE
L J M Caldon, S J Walters, J A Reed, A Murphy, A Worley and M W R Reed
Br J Cancer 92: 55-59; advance online publication, December 21, 2004; doi:10.1038/sj.bjc.6602264
A micro costing of NHS cancer genetic services FREE
G L Griffith, R Tudor-Edwards, J Gray, R Butler, C Wilkinson, J Turner, B France and P Bennett (The GenQuest research team)
Br J Cancer 92: 60-71; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602270
Translational Therapeutics
Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo FREE
A D Gritzapis, S A Perez, C N Baxevanis and M Papamichail
Br J Cancer 92: 72-79; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602259
H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells FREE
C Li, R-H Teng, Y-C Tsai, H-S Ke, J-Y Huang, C-C Chen, Y-L Kao, C-C Kuo, W R Bell and B Shieh
Br J Cancer 92: 80-88; advance online publication, December 21, 2004; doi:10.1038/sj.bjc.6602272
Molecular Diagnostics
Endostatin expression in pancreatic tissue is modulated by elastase FREE
R D Brammer, S R Bramhall and M C Eggo
Br J Cancer 92: 89-93; advance online publication, November 16, 2004; doi:10.1038/sj.bjc.6602234
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression FREE
A Couvelard, D O'Toole, H Turley, R Leek, A Sauvanet, C Degott, P Ruszniewski, J Belghiti, A L Harris, K Gatter and F Pezzella
Br J Cancer 92: 94-101; advance online publication, November 23, 2004; doi:10.1038/sj.bjc.6602245
Integrin 1 is required for the invasive behaviour but not proliferation of squamous cell carcinoma cells in vivo
FREE
E C Brockbank, J Bridges, C J Marshall and E Sahai
Br J Cancer 92: 102-112; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602255
Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma FREE
G Y Zhang, N Ahmed, C Riley, K Oliva, G Barker, M A Quinn and G E Rice
Br J Cancer 92: 113-119; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602244
Expression of survivin and its splice variants survivin-2B and survivin-
Ex3 in breast cancer FREE
B Ryan, N O'Donovan, B Browne, C O'Shea, J Crown, A D K Hill, E McDermott, N O'Higgins and M J Duffy
Br J Cancer 92: 120-124; advance online publication, December 21, 2004; doi:10.1038/sj.bjc.6602314
Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines FREE
S B Maddineni, V K Sangar, J H Hendry, G P Margison and N W Clarke
Br J Cancer 92: 125-130; advance online publication, December 21, 2004; doi:10.1038/sj.bjc.6602299
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis FREE
C Mascaux, N Iannino, B Martin, M Paesmans, T Berghmans, M Dusart, A Haller, P Lothaire, A-P Meert, S Noel, J-J Lafitte and J-P Sculier
Br J Cancer 92: 131-139; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602258
Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling FREE
Y Zhang and A W Hamburger
Br J Cancer 92: 140-146; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602257
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer FREE
R J Burcombe, A Makris, P I Richman, F M Daley, S Noble, M Pittam, D Wright, S A Allen, J Dove and G D Wilson
Br J Cancer 92: 147-155; advance online publication, December 21, 2004; doi:10.1038/sj.bjc.6602256
Epidemiology
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size FREE
L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio, E Buiatti and the SCREENREG Working Group
Br J Cancer 92: 156-161; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602289
Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening FREE
R Rawal, J Lorenzo Bermejo and K Hemminki
Br J Cancer 92: 162-166; advance online publication, November 30, 2004; doi:10.1038/sj.bjc.6602250
Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects FREE
G Albrektsen, I Heuch, S Hansen and G Kvåle
Br J Cancer 92: 167-175; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602302
Golestan cohort study of oesophageal cancer: feasibility and first results FREE
A Pourshams, M Saadatian-Elahi, M Nouraie, A F Malekshah, N Rakhshani, R Salahi, A Yoonessi, S Semnani, F Islami, M Sotoudeh, S Fahimi, A R Sadjadi, D Nasrollahzadeh, K Aghcheli, F Kamangar, C C Abnet, F Saidi, V Sewram, P T Strickland, S M Dawsey, P Brennan, P Boffetta and R Malekzadeh
Br J Cancer 92: 176-181; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602249
Impact of alcohol drinking on total cancer risk: data from a large-scale population-based cohort study in Japan FREE
M Inoue and S Tsugane for the JPHC Study Group
Br J Cancer 92: 182-187; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602277
Classic Kaposi's sarcoma in Italy, 1985–1998 FREE
L Dal Maso, J Polesel, V Ascoli, P Zambon, M Budroni, S Ferretti, R Tumino, G Tagliabue, S Patriarca, M Federico, M Vercelli, A Giacomin, G Vicario, F Bellù, F Falcini, E Crocetti, V De Lisi, S Vitarelli, S Piffer, F Stracci, D Serraino, G Rezza and S Franceschi for the Cancer and AIDS Registry Linkage (CARL) Study
Br J Cancer 92: 188-193; advance online publication, November 30, 2004; doi:10.1038/sj.bjc.6602265
The risk of cancer in HIV-infected people in southeast England: a cohort study FREE
A Newnham, J Harris, H S Evans, B G Evans and H Møller
Br J Cancer 92: 194-200; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602273
Atypical cancer pattern in patients with Parkinson's disease FREE
J H Olsen, S Friis, K Frederiksen, J K McLaughlin, L Mellemkjaer and H Møller
Br J Cancer 92: 201-205; advance online publication, December 7, 2004; doi:10.1038/sj.bjc.6602279
Letters to the Editor
Remarks on sentinel node biopsy in head and neck cancer FREE
A F Kovács
Br J Cancer 92: 206-207; advance online publication, December 14, 2004; doi:10.1038/sj.bjc.6602293
Reply: Remarks on sentinel node biopsy in head and neck cancer FREE
S Hoft and S Maune
Br J Cancer 92: 207-208; doi:10.1038/sj.bjc.6602294
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
